Free Trial
OTCMKTS:NUMIF

Numinus Wellness (NUMIF) Stock Price, News & Analysis

Numinus Wellness logo
C$0.03 +0.01 (+24.75%)
As of 05/9/2025 02:31 PM Eastern

About Numinus Wellness Stock (OTCMKTS:NUMIF)

Key Stats

Today's Range
C$0.02
C$0.03
50-Day Range
C$0.02
C$0.04
52-Week Range
C$0.01
C$0.08
Volume
10,125 shs
Average Volume
85,424 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies. The Canadian Clinic Network segment provides clinical services, including traditional therapy and counseling, ketamine-assisted therapies for depression, psychedelic-assisted therapies, mindfulness programs, and virtual psychotherapy services, as well as neurological care services. The US clinic network segment offers psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management services. The company also offers laboratory services, such as the cultivation, production, and extraction of natural Psilocybe and other psychoactive fungi species, the development of proprietary processes and products, methods for controlled psychedelics and development of a pipeline for product development, and protocol development and safety and efficacy studies; lab testing services; and psychedelic-assisted therapy training services. The company was incorporated in 1964 and is headquartered in Vancouver, Canada.

Receive NUMIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Numinus Wellness and its competitors with MarketBeat's FREE daily newsletter.

NUMIF Stock News Headlines

Numinus Wellness announces CFO transition
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?
Numinus Wellness Inc. Announces CFO Transition
See More Headlines

NUMIF Stock Analysis - Frequently Asked Questions

Numinus Wellness' stock was trading at C$0.03 at the start of the year. Since then, NUMIF stock has increased by 0.8% and is now trading at C$0.03.
View the best growth stocks for 2025 here
.

Shares of NUMIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
N/A
Current Symbol
OTCMKTS:NUMIF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:NUMIF) was last updated on 5/10/2025 by MarketBeat.com Staff
From Our Partners